Metformin 500 mg commonly causes digestive side effects, especially during the first few weeks of treatment. Most people experience some combination of nausea, diarrhea, bloating, or stomach discomfort when they start taking it. These symptoms are usually temporary and tend to fade as your body adjusts, but some side effects can develop later with long-term use.
Common Digestive Side Effects
The most frequent complaints with metformin 500 mg are gastrointestinal: diarrhea, nausea, vomiting, gas, and bloating. These are most likely to show up when you first start treatment and typically resolve on their own within a few days to weeks. Women are more likely than men to report these symptoms, particularly during the initial adjustment period.
The digestive effects happen because metformin changes how your gut absorbs glucose and alters the bacteria in your intestines. A 500 mg dose is the lowest standard dose, so these side effects tend to be milder than what people experience at higher doses like 1,000 or 2,000 mg daily. Still, they can be uncomfortable enough to make some people want to stop taking the medication before their body has had a chance to adapt.
How to Reduce Stomach Problems
Taking metformin with food is the single most effective way to cut down on nausea and diarrhea. An empty stomach makes side effects significantly worse. Starting at a lower dose and increasing gradually also helps your body adjust, which is why many prescriptions begin at 500 mg once daily before moving up.
There are also two formulations of metformin: immediate-release and extended-release. The extended-release version dissolves more slowly and delivers the drug over a longer period, which makes a real difference for digestive symptoms. A large meta-analysis published in Frontiers in Endocrinology found that immediate-release metformin carries a higher risk of both diarrhea and bloating compared to the extended-release version. If stomach problems persist beyond the first few weeks, switching formulations is a common next step.
Weight Changes
Unlike many diabetes medications, metformin does not cause weight gain. In fact, most people lose a modest amount of weight on it. In the Diabetes Prevention Program trial, participants taking metformin lost an average of 2.1 kg (about 4.6 pounds) over roughly three years, and that weight loss held steady over a full decade of follow-up, averaging 2.5 kg at the 10-year mark. By comparison, the placebo group lost almost nothing.
This weight effect is generally considered a benefit rather than a side effect. Interestingly, the amount of weight lost correlates directly with how consistently people take the medication, which suggests it isn’t just a byproduct of feeling nauseous and eating less. The weight loss is modest compared to newer medications, but it’s consistent and comes with very low cost and a strong safety record.
Vitamin B12 Deficiency
One of the less obvious side effects of metformin is that it can interfere with your body’s ability to absorb vitamin B12. This doesn’t happen right away. It develops gradually with long-term use, and the risk increases at higher doses and longer durations of treatment. Studies estimate that 10 to 30% of people taking metformin for extended periods develop some degree of B12 deficiency, with some research finding rates as high as 35%.
B12 deficiency can cause fatigue, weakness, numbness or tingling in the hands and feet, difficulty with balance, and memory problems. Because these symptoms overlap with diabetic nerve damage, they can easily be missed or attributed to diabetes itself rather than to the medication. If you’ve been on metformin for several years and notice new tingling or unusual fatigue, a simple blood test can check your B12 levels. Some people benefit from a B12 supplement while continuing metformin.
Metallic Taste
Some people notice a persistent metallic or unpleasant taste in their mouth after starting metformin. This is one of the more distinctive side effects and can affect appetite. Like the digestive symptoms, it tends to be most noticeable early in treatment and often fades with time. Taking the medication with a meal can help reduce it.
Lactic Acidosis: A Rare but Serious Risk
Lactic acidosis is the most serious potential complication of metformin, but it is extremely uncommon. The estimated incidence is fewer than 10 cases per 100,000 patient-years. To put that in perspective, if 100,000 people took metformin for a full year, fewer than 10 would develop this condition.
Lactic acidosis occurs when lactic acid builds up in the blood faster than the body can clear it. It almost never happens in people with healthy kidneys. The typical scenario involves someone whose kidney function is significantly reduced, combined with a second stressor like a severe infection, dehydration, or a major medical event that further disrupts the body’s ability to process the drug. Symptoms include muscle pain, difficulty breathing, unusual sleepiness, and feeling cold or dizzy.
Because kidney function is the primary safety concern, metformin doses are adjusted based on how well your kidneys are working. People with mildly reduced kidney function can safely take up to 1,000 mg daily, while those with more significant impairment are typically limited to 500 mg. The medication is only fully contraindicated when kidney function drops to very low levels. Your kidney function is routinely checked through blood work, and your dose may be adjusted over time if those numbers change.
What to Expect Over Time
The side effect profile of metformin shifts as you move from short-term to long-term use. In the first one to four weeks, digestive symptoms are at their peak. Most people find these settle considerably by the end of the first month, especially if they’re taking the medication with meals and started at a low dose. If you’re still experiencing significant nausea or diarrhea after four to six weeks, it’s worth discussing the extended-release formulation or a dose adjustment.
Over the long term, the main concern shifts to B12 absorption. The digestive side effects that dominate early treatment rarely persist at the same intensity. For the majority of people, metformin at 500 mg is well tolerated once the initial adjustment period passes, which is part of why it remains the most widely prescribed first-line treatment for type 2 diabetes worldwide.